Press Releases


Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines

March 31, 2020

Tags |  Corporate

INDIANAPOLIS and OXFORD, England , March 31, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in




Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic

March 23, 2020

Tags |  Corporate

INDIANAPOLIS , March 23, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today provided an update on the company's clinical trial activities in light of the COVID-19 pandemic. The company will delay most new study starts and pause enrollment in most ongoing studies.




Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers

March 22, 2020

Tags |  Corporate

INDIANAPOLIS , March 22, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area health care workers beginning Monday, March 23 , as a service to the community and in an effort to protect health care




Kathryn Beiser to join Lilly as Vice President, Global Communications

March 20, 2020

Tags |  Corporate

INDIANAPOLIS , March 20, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) announced today that Kathryn Beiser will join the company on April 6, 2020 as vice president, global communications. In this role, Beiser will oversee all aspects of the company's corporate communications strategy,




Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories

March 18, 2020

Tags |  Corporate

INDIANAPOLIS , March 18, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) announced today its scientists are partnering with the Indiana State Department of Health (ISDH), with support from the Food and Drug Administration (FDA), to accelerate testing in Indiana for SARS-CoV-2, the virus that




AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19

March 12, 2020

Tags |  Corporate

AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create antibody therapeutics for treatment and prevention of COVID-19 VANCOUVER, British Columbia and INDIANAPOLIS , March 12, 2020 /PRNewswire/ -- AbCellera and




Lilly Statement on Novel Coronavirus and the Reliable Supply of the Company's Medicines

March 3, 2020

Tags |  Corporate

INDIANAPOLIS , March 3, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) issued the following statement today regarding the novel coronavirus: Among the concerns raised due to the impact of the novel coronavirus is whether patients can count on a reliable supply of medicine.




Lilly Completes Acquisition of Dermira

February 20, 2020

Tags |  Corporate

INDIANAPOLIS , Feb. 20, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition expands Lilly's immunology pipeline with the addition of lebrikizumab, a novel, investigational, monoclonal




Anat Hakim to join Lilly as General Counsel

January 24, 2020

Tags |  Corporate

INDIANAPOLIS , Jan. 24, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Anat Hakim will join the company on February 3, 2020 as senior vice-president and general counsel. Hakim succeeds Michael J. Harrington who will retire on January 31 , 2020.  "I am excited to welcome




Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant

January 21, 2020

Tags |  Corporate

Company will invest more than $470 million to build new manufacturing facility RALEIGH, N.C. , Jan. 21, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs in Durham , Governor